0000912282-23-000135.txt : 20230620
0000912282-23-000135.hdr.sgml : 20230620
20230620082912
ACCESSION NUMBER: 0000912282-23-000135
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230425
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PYSZCZYMUKA GREG
CENTRAL INDEX KEY: 0001952920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38247
FILM NUMBER: 231023485
MAIL ADDRESS:
STREET 1: C/O AYTU BIOPHARMA, INC.
STREET 2: 373 INVERNESS PARKWAY, SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER NAME:
FORMER CONFORMED NAME: PYSZCAYMUKA GREG
DATE OF NAME CHANGE: 20221031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AYTU BIOPHARMA, INC
CENTRAL INDEX KEY: 0001385818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 470883144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 373 INVERNESS PARKWAY
STREET 2: SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: (720) 437-6580
MAIL ADDRESS:
STREET 1: 373 INVERNESS PARKWAY
STREET 2: SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC
DATE OF NAME CHANGE: 20150609
FORMER COMPANY:
FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC.
DATE OF NAME CHANGE: 20150609
FORMER COMPANY:
FORMER CONFORMED NAME: Rosewind CORP
DATE OF NAME CHANGE: 20070110
4
1
form4.xml
X0407
4
2023-04-25
0001385818
AYTU BIOPHARMA, INC
AYTU
0001952920
PYSZCZYMUKA GREG
C/O AYTU BIOPHARMA, INC.
373 INVERNESS PARKWAY, SUITE 206
ENGLEWOOD
CO
80112
true
Chief Commerical Officer
false
Common Shares
2023-04-25
4
M
0
833
0
A
9935
D
Restricted Stock Units
2023-04-25
4
M
0
833
0
D
Common Shares
833
1667
D
Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023.
Represents restricted stock units ("RSU"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest as follows: One-third on March 31, 2023; 1/12th of the original grant quarterly thereafter through March 31, 2025. Settlement of vested RSUs will occur as soon as practicable following vesting.
/s/ Mark Oki as attorney-in-fact for Greg Pyszczymuka
2023-06-19